These findings suggest that the combination of metformin and insulin may promote adipogenesis by reducing oxidative stress and inflammation, which may be of therapeutic benefit in the treatment of adipose tissue dysfunction in T2DM and insulin resistance [72]. The gene discussed is INS; the disease is type 2 diabetes mellitus.